Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The use of nanoparticles is crucial for the development of a new generation of nanodevices for clinical applications. Silica-based nanoparticles can be tailored with a wide range of functional biopolymers with unique physicochemical properties thus providing several advantages: (1) limitation of interparticle interaction, (2) preservation of cargo and particle integrity, (3) reduction of immune response, (4) additional therapeutic effects and (5) cell targeting. Therefore, the engineering of advanced functional coatings is of utmost importance to enhance the biocompatibility of existing biomaterials. Herein we will focus on the most recent advances reported on the delivery and therapeutic use of silica-based nanoparticles containing biopolymers (proteins, nucleotides, and polysaccharides) with proven biological effects.

Cite

CITATION STYLE

APA

Gándara, Z., Rubio, N., & Castillo, R. R. (2023, February 1). Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems. Pharmaceutics. MDPI. https://doi.org/10.3390/pharmaceutics15020351

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free